Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Neurology
•
Neuro-immunology
How do you decide on long term immunosuppression therapy for Susac Syndrome?
Related Questions
In a patient with strong serologic evidence of SLE presenting with isolated bilateral lower limb sensorimotor neuropathy, normal neuroimaging, and CSF, would you initiate cyclophosphamide with pulse-dose steroids upfront, or reserve escalation (e.g., plasma exchange or immunosuppressants) for cases refractory to steroids?
What are your vaccine recommendations while patients are on biologics?
What is the role of skin biopsy for evaluating small fiber neuropathy in patients with rheumatic disease who have treatment recalcitrant pain?
Should IVIG dosing in patients with autoimmune disease (i.e., dermatomyositis) who become pregnant continue to be based on actual weight at the time of each infusion, or should it be limited to pre-pregnancy weight?
What is the role of inebilizumab in the maintenance treatment of IgG4-related disease?
How can we minimize the risk of overinterpreting reactive findings from repeat lumbar punctures?
How would you manage a patient with LGI-1 encephalitis with faciobracial dystonic seizures who has not improved with 3 days of intravenous steroids?
What criteria do you use to differentiate between MOGAD and MS in pediatric patients?
What biomarkers best predict the response to B-cell depleting therapies in MS?
Do you always biopsy patients who present with classic skin findings of dermatomyositis?
